ProQR Therapeutics BV (PRQR) — Capital Reinvestment Ratio
ProQR Therapeutics BV (PRQR) has a Capital Reinvestment Ratio of 0.00x as of March 2023, meaning it reinvests 0% of its operating cash flow ($44.73 Million) in capital expenditures ($136.00K). Check tangible equity quality of ProQR Therapeutics BV to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
ProQR Therapeutics BV Capital Reinvestment Ratio (2023–2023)
This chart tracks ProQR Therapeutics BV's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see ProQR Therapeutics BV (PRQR) cash flow conversion.
Annual Capital Reinvestment Ratio for ProQR Therapeutics BV (2023–2023)
Year-by-year Capital Reinvestment Ratio for ProQR Therapeutics BV from 2023 to 2023. See PRQR free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.06x | $21.55 Million | $1.37 Million | — |